Overview A Study to Explore the Routes of Elimination of MDV3100 Status: Completed Trial end date: 2011-07-01 Target enrollment: Participant gender: Summary A study to investigate the excretion routes of radio-labelled MDV3100. Phase: Phase 1 Details Lead Sponsor: Astellas Pharma Europe B.V.Collaborator: Medivation, Inc.